119 - FACTORES PREDICTIVOS DE RESPUESTA A FILGOTINIB EN COLITIS ULCEROSA: ANÁLISIS POST HOC DEL ESTUDIO SELECTION Carlos Taxonera; Brian Feagan; Laurent Peyrin-Biroulet; Edouard Louis; Virginia Taliadouros; Franck-Olivier Le Brun; Alessandra Oortwijn; Haridarshan Patel; Angela de Haas; Tadakazu Hisamatsu;

122 - MODELOS DE TRAYECTORIAS PARA IDENTIFICAR DIFERENTES RESPUESTAS INDIVIDUALES A FILGOTINIB: ANÁLISIS POST HOC DEL ESTUDIO SELECTION Miquel Sans Cuffi; Stefan Schreiber; Laurent Peyrin-Biroulet; Toshifumi Hibi; Louis Dron; Claus A. Andersen; Alessandra Oortwijn; Haridarshan Patel; Brian Feagan;

111 - EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN¿S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- EXCEL STUDY Edward V. Loftus; Jean-Frederic Colombel; Ana Paula Lacerda; Laurent Peyrin-Biroulet; Geert D¿Haens; Remo Panaccione; Walter Reinisch; Edouard Louis; Minhu Chen; Hiroshi Nakase; Susan Greenbloom; George DuVall; Yuri Sánchez González; Mohamed-Eslam F. Mohamed; Susan Rhee; Tian Feng; Elena Dubcenco; Julián Panés;